Jianguo Yang

Jianguo Yang

Auto-generated profile, based on publicly available information

Jianguo Yang

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2023 in Medicine
Verified
Journal Article
Open access
JYJianguo Mm Yang
Jianguo Mm Yang
FZFuyu Mm Zhou
Fuyu Mm Zhou
XZXinpeng Zhou
Xinpeng Zhou
YSYuying Sun
Yuying Sun
XLXueping Lun
Xueping Lun
BFBing Fan
Bing Fan
Background: The study aimed to evaluate survival rates and prognosis in systemic lupus erythematosus (SLE) patients with pulmonary hypertension (PH) using meta-analysis. Methods: PubMed, EMBASE, Cochrane central register of controlled trials, China National Knowledge Infrastructure, China Science and Technology Journal Database, Wan-Fang Database, and Chinese biomedical database were searched. Information and data were screened and extracted by 2 researchers. The obtained data were analyzed using the R software meta package. Quality assessment was conducted using Newcastle-Ottawa Scale. The causes of heterogeneity were analyzed using subgroup analysis and sensitivity analysis. Publication bias was evaluated using Begger funnel plots and Egger test. Results: The search strategy yielded a total of 21 studies involving 875 patients included in the final analysis. The pooled 1-, 3- and 5-year survival rates of patients with SLE-PH were 0.9020 (95%CI: 0.8576; 0.9397), 0.8363 (96%CI: 0.7813; 0.8852), 0.7301 (95%CI: 0.6327; 0.8181). The 1-, 3- and 5-year survival rates of echocardiography subgroup were 0.9000 (95%CI: 0.8480; 0.9551), 0.8435 (95%CI: 0.7744; 0.9187), 0.6795 (95%CI: 0.5746; 0.8035), respectively; and there were 0.9174 (95%CI: 0.8951; 0.9402), 0.8529 (95%CI: 0.8255; 0.8812), 0.7757 (95%CI: 0.7409; 0.8121) at right heart catheterization subgroup in the meantime. Multivariate analysis for predicting mortality in SLE-PH patients revealed that diminishing left ventricular ejection fraction, New York Heart Association classification, lupus nephritis, lower cardiac index, and higher red blood cell distribution width level were significantly associated with a higher mortality rate. Treatment with huge doses of cyclophosphamide, tricuspid annular plane systolic excursion/pulmonary artery systolic pressure, and Raynaud phenomenon signaled favorable outcomes. Conclusion: The 1-, 3-, and 5-year survival rates of SLE-PH patients in recent years (0.9020, 0.8363, 0.7301) were estimated in this study. SLE-PH patients diagnosed by echocardiography have a worse long-term prognosis than those diagnosed by right heart catheterization. Studies after 2015 have shown significantly better survival than earlier studies.

6 April 2023
Verified
Report
Open access
JYJianguo Yang
Jianguo Yang
SMShandong University of Traditional Chinese Medicine
Shandong University of Traditional Chinese Medicine
FZFuyu Zhao
Fuyu Zhao
XZXinpeng Zhou
Xinpeng Zhou
YSYuying Sun
Yuying Sun
BFBing Fan
Bing Fan
INPLASY202340017 Survival and prognosis analysis of systemic lupus erythematosus-pulmonary hypertension: a protocol for systematic review and meta-analysis Keywords: SLE, PH, survival rate, prognos…

10 April 2024
Verified
Report
Closed access
JYJianguo Yang
Jianguo Yang
YSYing Sun
Ying Sun
PZPeng Zhou
Peng Zhou
DZDi Zhang
Di Zhang
ZXZiqi Xu
Ziqi Xu
BFBing Fan
Bing Fan
INPLASY202440048 Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis Keywords: secondary autoimmune diseases, alemtuzumab,…